Acknowledgement
This work was supported by the 2023 education, research and student guidance grant funded by Jeju National University.
References
- ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. 9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes-2023. Diabetes Care 2023;46(Suppl 1):S140-57. https://doi.org/10.2337/dc23-S009
- Hsia DS, Grove O, Cefalu WT. An update on sodium-glucose co-transporter-2 inhibitors for the treatment of diabetes mellitus. Curr Opin Endocrinol Diabetes Obes 2017;24:73-9. https://doi.org/10.1097/MED.0000000000000311
- Inoue A, Katayama A, Sue M, Hasegawa M, Maeda M, Matoba M, et al. Euglycemic diabetic ketoacidosis in a patient with type 2 diabetes mellitus 3days after initiating sodium-glucose cotransporter 2 inhibitor while on an extremely low carbohydrate diet: a case report. Clin Case Rep 2022;10:e6572.
- Mistry S, Eschler DC. Euglycemic diabetic ketoacidosis caused by SGLT2 inhibitors and a ketogenic diet: a case series and review of literature. AACE Clin Case Rep 2020;7:17-9. https://doi.org/10.1016/j.aace.2020.11.009
- Choi JH, Cho YJ, Kim HJ, Ko SH, Chon S, Kang JH, et al. Effect of carbohydrate-restricted diets and intermittent fasting on obesity, type 2 diabetes mellitus, and hypertension management: consensus statement of the Korean Society for the Study of Obesity, Korean Diabetes Association, and Korean Society of Hypertension. Diabetes Metab J 2022;46:355-76. https://doi.org/10.4093/dmj.2022.0038
- Evert AB, Dennison M, Gardner CD, Garvey WT, Lau KHK, MacLeod J, et al. Nutrition therapy for adults with diabetes or prediabetes: a consensus report. Diabetes Care 2019;42:731-54. https://doi.org/10.2337/dci19-0014
- Palmer BF, Clegg DJ. Euglycemic ketoacidosis as a complication of SGLT2 inhibitor therapy. Clin J Am Soc Nephrol 2021;16:1284-91. https://doi.org/10.2215/CJN.17621120
- Health Insurance Review & Assessment Service. Standards for approving Korean National Health Insurance coverage of medications used for the treatment of diabetes [Internet]. Wonju: Korean Health Insurance Review & Assessment Service; c2023 [cited 2023 Apr 25]. Available from: https://www.hira.or.kr/rc/insu/insuadtcrtr/InsuAdtCrtrList.do?pgmid=HIRAA030069000400&WT.ac=%EB%B3%B4%ED%97%98%EC%9D%B8%EC%A0%95%EA%B8%B0%EC%A4%80%EB%B0%94%EB%A1%9C%EA%B0%80%EA%B8%B0.
- Paoli A, Rubini A, Volek JS, Grimaldi KA. Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets. Eur J Clin Nutr 2013;67:789-96. https://doi.org/10.1038/ejcn.2013.116
- Sainsbury E, Kizirian NV, Partridge SR, Gill T, Colagiuri S, Gibson AA. Effect of dietary carbohydrate restriction on glycemic control in adults with diabetes: a systematic review and meta-analysis. Diabetes Res Clin Pract 2018;139:239-52. https://doi.org/10.1016/j.diabres.2018.02.026